![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profileg](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
Cancer Research, Statistics and Treatment
@CRSTonline
Peer-reviewed open-access journal for research & info on cancer. Web: https://t.co/igQRhLOmq9; Email: [email protected]; Facebook: @CRSTonline
ID:1118465129262108673
http://CRSTonline.com 17-04-2019 10:44:01
369 Tweets
1,9K Followers
170 Following
![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
Indian patients with NSCLC have 29% EGFR positivity, 8.1% ALK positivity, and 3.5% ROS1 positivity, when tested with RT-PCR, IHC, and FISH. Read the molecular profile by Dr Munde and team here: bit.ly/3TVVjYS #CRST #ALK #ROS1 #EGFR #CancerResearch #MedTwitter
![Cancer Research, Statistics and Treatment (@CRSTonline) on Twitter photo 2024-04-10 12:54:34 Indian patients with NSCLC have 29% EGFR positivity, 8.1% ALK positivity, and 3.5% ROS1 positivity, when tested with RT-PCR, IHC, and FISH. Read the molecular profile by Dr Munde and team here: bit.ly/3TVVjYS #CRST #ALK #ROS1 #EGFR #CancerResearch #MedTwitter Indian patients with NSCLC have 29% EGFR positivity, 8.1% ALK positivity, and 3.5% ROS1 positivity, when tested with RT-PCR, IHC, and FISH. Read the molecular profile by Dr Munde and team here: bit.ly/3TVVjYS #CRST #ALK #ROS1 #EGFR #CancerResearch #MedTwitter](https://pbs.twimg.com/media/GKzhfm8XoAEZcYx.jpg)
![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
Dr Singh and team assess the 8-year long-term superiority of gefitinib over chemotherapy in terms of overall and progression-free survival (PFS), objective response rate (ORR), and safety. Read here: bit.ly/4azKlis #CRST #oncology #MedTwitter #cancer #CancerResearch
![Cancer Research, Statistics and Treatment (@CRSTonline) on Twitter photo 2024-04-04 12:09:07 Dr Singh and team assess the 8-year long-term superiority of gefitinib over chemotherapy in terms of overall and progression-free survival (PFS), objective response rate (ORR), and safety. Read here: bit.ly/4azKlis #CRST #oncology #MedTwitter #cancer #CancerResearch Dr Singh and team assess the 8-year long-term superiority of gefitinib over chemotherapy in terms of overall and progression-free survival (PFS), objective response rate (ORR), and safety. Read here: bit.ly/4azKlis #CRST #oncology #MedTwitter #cancer #CancerResearch](https://pbs.twimg.com/media/GKUdjf9WEAAfoX3.jpg)
![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
Dr. Malik and team present a clinico-epidemiologic study of head-and-neck cancer patients from Haryana, India. The male-to-female ratio was 8.6:1 with a high incidence of oropharyngeal cancer. Read on: bit.ly
#CRST #cancer #oncologia #MedTwitter #CancerResearch
![Cancer Research, Statistics and Treatment (@CRSTonline) on Twitter photo 2024-03-27 11:36:58 Dr. Malik and team present a clinico-epidemiologic study of head-and-neck cancer patients from Haryana, India. The male-to-female ratio was 8.6:1 with a high incidence of oropharyngeal cancer. Read on: bit.ly #CRST #cancer #oncologia #MedTwitter #CancerResearch Dr. Malik and team present a clinico-epidemiologic study of head-and-neck cancer patients from Haryana, India. The male-to-female ratio was 8.6:1 with a high incidence of oropharyngeal cancer. Read on: bit.ly #CRST #cancer #oncologia #MedTwitter #CancerResearch](https://pbs.twimg.com/media/GJrJeZ3XcAAPavB.jpg)
![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
Our new issue is live! Looking forward to your comments and criticism. Sincere thanks to all authors, reviewers, editors and publishers for your contribution.
Read here: bit.ly/3Kf29px
Vanita Noronha, MBBS MD DM Tata Memorial Hospital #CRST #oncology #CancerResearch #MedTwitter
![Cancer Research, Statistics and Treatment (@CRSTonline) on Twitter photo 2024-03-25 04:58:32 Our new issue is live! Looking forward to your comments and criticism. Sincere thanks to all authors, reviewers, editors and publishers for your contribution. Read here: bit.ly/3Kf29px @VanitaNoronha @TataMemorial #CRST #oncology #CancerResearch #MedTwitter Our new issue is live! Looking forward to your comments and criticism. Sincere thanks to all authors, reviewers, editors and publishers for your contribution. Read here: bit.ly/3Kf29px @VanitaNoronha @TataMemorial #CRST #oncology #CancerResearch #MedTwitter](https://pbs.twimg.com/media/GJfbGsPWsAAgNhj.jpg)
![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
Head-and-neck cancers account for 30-40% of all cancer cases in India. Dr. Prabhash et al. present an update to Indian clinical guidelines for the management of HNSCC. Read here: bit.ly/3UkTTZZ
#headandneckcancer #CRST #CancerTreatment #Cancers #MedTwitter #HNSCC
![Cancer Research, Statistics and Treatment (@CRSTonline) on Twitter photo 2024-01-30 11:21:00 Head-and-neck cancers account for 30-40% of all cancer cases in India. Dr. Prabhash et al. present an update to Indian clinical guidelines for the management of HNSCC. Read here: bit.ly/3UkTTZZ #headandneckcancer #CRST #CancerTreatment #Cancers #MedTwitter #HNSCC Head-and-neck cancers account for 30-40% of all cancer cases in India. Dr. Prabhash et al. present an update to Indian clinical guidelines for the management of HNSCC. Read here: bit.ly/3UkTTZZ #headandneckcancer #CRST #CancerTreatment #Cancers #MedTwitter #HNSCC](https://pbs.twimg.com/media/GFFXuV3bIAAGnzL.jpg)
![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
Dr. Jha and team identify a rare EGFR exon 18 mutation in lung adenocarcinoma using targeted next-generation sequencing. Read the molecular tumor board article here: bit.ly/3NQMIV9 #CRST #moleculartumorboard #genetics #EGFR #lungcancer #cancer #medtwitter
![Cancer Research, Statistics and Treatment (@CRSTonline) on Twitter photo 2024-01-09 13:00:45 Dr. Jha and team identify a rare EGFR exon 18 mutation in lung adenocarcinoma using targeted next-generation sequencing. Read the molecular tumor board article here: bit.ly/3NQMIV9 #CRST #moleculartumorboard #genetics #EGFR #lungcancer #cancer #medtwitter Dr. Jha and team identify a rare EGFR exon 18 mutation in lung adenocarcinoma using targeted next-generation sequencing. Read the molecular tumor board article here: bit.ly/3NQMIV9 #CRST #moleculartumorboard #genetics #EGFR #lungcancer #cancer #medtwitter](https://pbs.twimg.com/media/GDZwpMkWwAEM2Ki.jpg)
![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
Is pain under-treated in older patients with cancer? Dr. Sehgal and team study the prevalence of untreated pain, pattern of analgesic use in older Indian patients. Read here: bit.ly/3HbCfjB
#CRST #geriatric #oncology #analgesics #CancerResearch #MedTwitter #cancer
![Cancer Research, Statistics and Treatment (@CRSTonline) on Twitter photo 2024-01-08 12:14:37 Is pain under-treated in older patients with cancer? Dr. Sehgal and team study the prevalence of untreated pain, pattern of analgesic use in older Indian patients. Read here: bit.ly/3HbCfjB #CRST #geriatric #oncology #analgesics #CancerResearch #MedTwitter #cancer Is pain under-treated in older patients with cancer? Dr. Sehgal and team study the prevalence of untreated pain, pattern of analgesic use in older Indian patients. Read here: bit.ly/3HbCfjB #CRST #geriatric #oncology #analgesics #CancerResearch #MedTwitter #cancer](https://pbs.twimg.com/media/GDUcf0oXYAEbRvI.jpg)
![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
What is the prevalence of preoperative anxiety and depression in patients undergoing major oncosurgeries? Dr. Opneja and team present a study from Kerala, India. Read here: bit.ly/47nNQXs #CancerResearch #anxiety #depression #cancer #surgery #oncology #MedTwitter #CRST
![Cancer Research, Statistics and Treatment (@CRSTonline) on Twitter photo 2024-01-05 11:50:43 What is the prevalence of preoperative anxiety and depression in patients undergoing major oncosurgeries? Dr. Opneja and team present a study from Kerala, India. Read here: bit.ly/47nNQXs #CancerResearch #anxiety #depression #cancer #surgery #oncology #MedTwitter #CRST What is the prevalence of preoperative anxiety and depression in patients undergoing major oncosurgeries? Dr. Opneja and team present a study from Kerala, India. Read here: bit.ly/47nNQXs #CancerResearch #anxiety #depression #cancer #surgery #oncology #MedTwitter #CRST](https://pbs.twimg.com/media/GDE6PxNXMAEUgw0.jpg)
![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
What is the prevalence of comorbidities in Indian patients with cancer? Sebastian at al. take a deep dive in their study from Malabar Cancer Center, Kerala, India. Read here: bit.ly/3RMiYtI
#CRST #CancerResearch #MedTwitter #oncologia #cancer #cancer awareness
![Cancer Research, Statistics and Treatment (@CRSTonline) on Twitter photo 2024-01-02 13:56:24 What is the prevalence of comorbidities in Indian patients with cancer? Sebastian at al. take a deep dive in their study from Malabar Cancer Center, Kerala, India. Read here: bit.ly/3RMiYtI #CRST #CancerResearch #MedTwitter #oncologia #cancer #cancerawareness What is the prevalence of comorbidities in Indian patients with cancer? Sebastian at al. take a deep dive in their study from Malabar Cancer Center, Kerala, India. Read here: bit.ly/3RMiYtI #CRST #CancerResearch #MedTwitter #oncologia #cancer #cancerawareness](https://pbs.twimg.com/media/GC16PW0WoAAvYqn.jpg)
![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
Parween et al. present a pan-cancer analysis of homologous recombination DNA repair pathway genes in the Indian population. Read here: bit.ly/3GXbtvh
#CancerResearch #CRST #Oncology #DNA #MedTwitter
![Cancer Research, Statistics and Treatment (@CRSTonline) on Twitter photo 2023-12-28 15:10:05 Parween et al. present a pan-cancer analysis of homologous recombination DNA repair pathway genes in the Indian population. Read here: bit.ly/3GXbtvh #CancerResearch #CRST #Oncology #DNA #MedTwitter Parween et al. present a pan-cancer analysis of homologous recombination DNA repair pathway genes in the Indian population. Read here: bit.ly/3GXbtvh #CancerResearch #CRST #Oncology #DNA #MedTwitter](https://pbs.twimg.com/media/GCcbB6QXUAAJy0P.jpg)
![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
In their study from Turkey, Dr. Kaplan and team assess the relationship between self-compassion, post-traumatic growth, and body image in patients with breast cancer. Read here: bit.ly/41EsBQ3
#CRST #oncology #Cancer Research #Cancer #MedTwitter #Turkey #breastcancer
![Cancer Research, Statistics and Treatment (@CRSTonline) on Twitter photo 2023-12-27 11:09:42 In their study from Turkey, Dr. Kaplan and team assess the relationship between self-compassion, post-traumatic growth, and body image in patients with breast cancer. Read here: bit.ly/41EsBQ3 #CRST #oncology #CancerResearch #Cancer #MedTwitter #Turkey #breastcancer In their study from Turkey, Dr. Kaplan and team assess the relationship between self-compassion, post-traumatic growth, and body image in patients with breast cancer. Read here: bit.ly/41EsBQ3 #CRST #oncology #CancerResearch #Cancer #MedTwitter #Turkey #breastcancer](https://pbs.twimg.com/media/GCWaAUIaUAMupcX.jpg)
![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Sharada Mailankody. Sharada Mailankody
![Cancer Research, Statistics and Treatment (@CRSTonline) on Twitter photo 2023-12-23 08:29:05 We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Sharada Mailankody. @SharadaMlankody We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Sharada Mailankody. @SharadaMlankody](https://pbs.twimg.com/media/GCBPcCNXkAAxQ38.jpg)
![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Ankita Nachankar. ANKITA NACHANKAR
![Cancer Research, Statistics and Treatment (@CRSTonline) on Twitter photo 2023-12-23 08:28:01 We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Ankita Nachankar. @drankitan We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Ankita Nachankar. @drankitan](https://pbs.twimg.com/media/GCBPMB-XoAA-i9T.jpg)
![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Prabhat Bhargava. Prabhat Bhargava, DM (Medical Oncology)
![Cancer Research, Statistics and Treatment (@CRSTonline) on Twitter photo 2023-12-23 08:10:27 We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Prabhat Bhargava. @bhargava611 We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Prabhat Bhargava. @bhargava611](https://pbs.twimg.com/media/GCBLJ6GXcAAL3CA.jpg)
![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Saquib Banday. Saquib Zaffar Banday
![Cancer Research, Statistics and Treatment (@CRSTonline) on Twitter photo 2023-12-23 08:07:47 We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Saquib Banday. @BandaySaquib We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Saquib Banday. @BandaySaquib](https://pbs.twimg.com/media/GCBKkIpWEAAH7zP.jpg)
![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Dilip Vallathol. Dilip Harindran Vallathol
![Cancer Research, Statistics and Treatment (@CRSTonline) on Twitter photo 2023-12-23 08:06:36 We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Dilip Vallathol. @Diliphv86 We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Dilip Vallathol. @Diliphv86](https://pbs.twimg.com/media/GCBKRi1WoAEXVKw.jpg)
![Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo Cancer Research, Statistics and Treatment(@CRSTonline) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1118467243946364928/u9PVErSV_200x200.jpg)
We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Kunal Jobanputra. Dr Kunal Jobanputra MD, DM
![Cancer Research, Statistics and Treatment (@CRSTonline) on Twitter photo 2023-12-23 08:04:54 We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Kunal Jobanputra. @KNJobanputra We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Kunal Jobanputra. @KNJobanputra](https://pbs.twimg.com/media/GCBJ1k7WMAAMN4D.jpg)